FDA Delays Effective Date of Sodium Labeling Rule for Over-the-Counter Drugs

Summary

The US Food and Drug Administration (FDA) is pushing back the effective date of a rule requiring sodium labeling on over-the-counter (OTC) medications, except those containing sodium bicarbonate, phosphate, or biphosphate, to align with the upcoming effective date of a separate rule on calcium, magnesium, and potassium labeling.